Evidence map›Paper›PMID 40815147›Full record

ArticlemBio2025

KSHV and HPV modulate epithelial-to-mesenchymal transition in oral epithelial cells.

Qian Li, Sharon E Hopcraft, Philip T Lange, Linda Pluta, Dirk P Dittmer, Cary A Moody, Blossom Damania

Abstract read
In one paragraph

Article in mBio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Qian LiLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.ORCID 0009-0007-7595-377X
Sharon E HopcraftLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Philip T LangeLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Linda PlutaLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Dirk P DittmerLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.ORCID 0000-0003-4968-5656
Cary A MoodyLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.ORCID 0000-0002-1991-0640
Blossom DamaniaLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.ORCID 0000-0002-9205-1774

Funding

Vironomics and Biostatistics CoreP01CA019014 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BLOSSOM A DAMANIA, NANCY JOAN RAAB-TRAUB · 1985 to 2026
$43.8M
The road to recovery: An assessment of patient-reported quality of life among cancer survivors in Malawi.U54CA254564 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAMANIA, BLOSSOM A · 2020 to 2024
$6.1M
Targeted Therapies for HIV-Associated Kaposi Sarcoma and LymphomaR01CA163217 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BLOSSOM A DAMANIA, Dirk P Dittmer · 2011 to 2026
$5.5M
NCI NIH HHS P01 CA019014NCI NIH HHS R01 CA163217NCI NIH HHS U54 CA254564NIH HHS CA019014NIH HHS CA163217NIH HHS CA254564
6 · The paper itself

Abstract

Most oral viral infections that manifest as oral diseases or cancers are caused by oncogenic human papillomavirus and herpesviruses. However, the mechanisms involved in the association between oral cancer and oncogenic virus infection are not well understood. In this study, we used telomerase (hTERT) -immortalized normal oral gingival keratinocytes (NOKs) and generated latent Kaposi's sarcoma-associated herpesvirus (KSHV)- and human papillomavirus 31 (HPV31)-infected NOKs. NOKs either stably maintaining HPV episomes or latently infected with KSHV acquired a fibroblast-like morphology and upregulated cell proliferation in both complete media and serum starvation culture conditions. Moreover, migration and invasion assays revealed that the KSHV- and HPV-infected NOKs show markedly higher migration and invasion activity compared to uninfected cells. We demonstrated that KSHV-NOK and HPV-NOK express much lower protein levels of the epithelial cell marker E-cadherin and significantly higher protein levels of mesenchymal cell marker vimentin, indicating that KSHV and HPV31 infection induces an epithelial-to-mesenchymal transition (EMT). Notably, after efficient vimentin knockdown using two different lentiviral short hairpin RNAs (shRNAs) or eribulin treatment, E-cadherin expression was restored, and phenotypic alterations (proliferation, migration, and invasion) caused by KSHV and HPV31 infection were abolished, suggesting that KSHV- and HPV31-induced EMTs play an important role in these phenotypic alterations by KSHV and HPV31. Given that changes in EMT are often associated with cancer progression, our results offer important insight into the mechanism behind KSHV and HPV infection and cancer, suggesting that EMT is a potential therapeutic target for KSHV- and HPV-driven cancers.IMPORTANCEThe oral cavity is believed to be a primary site where many viruses infect the human body. Kaposi's sarcoma-associated herpesvirus (KSHV) and human papillomavirus (HPV) are both found and cause cancers in the oral cavity. However, knowledge of how KSHV and HPV infection is connected to oral cancer (e.g., oncogenesis and metastasis) remains limited. Here, our study reveals that KSHV and high-risk HPV31 can induce epithelial-to-mesenchymal transition by upregulation of vimentin and downregulation of E-cadherin, which is vital for KSHV-normal oral gingival keratinocyte (NOK) and HPV-NOK to acquire cancer cell characteristics such as cell survival, migration, and invasion activities. For the first time, we show that knockdown of vimentin and eribulin treatment can restore E-cadherin and reverse epithelial-to-mesenchymal transition in KSHV- and HPV31-infected oral epithelial cells. These findings fill a gap in our understanding of oncogenesis and metastasis of oral cancers caused by KSHV and HPV31, revealing that vimentin may serve as a potential therapeutic molecular target for KSHV- and HPV-associated oral cancer.

Indexed as

Epithelial CellsEpithelial-Mesenchymal TransitionHerpesvirus 8, HumanCadherinsCell LineCell MovementCell ProliferationGingivaHumansKeratinocytesVimentinCadherinsVimentinEMTeribulinHPV31human oncovirusesinvasionKSHVmigrationoral epithelial cellproliferationvimentin

Identifiers

PMID40815147
PMCPMC12421897

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.